Account Bag 0

PRODUCT PROFILE

ADINA Epithalon product vial

Epithalon

£58.00

Epithalon is synthetic tetrapeptide ala-glu-asp-gly. Researchers examine it in relation to telomere, circadian and cellular-ageing hypotheses.

Why it is distinct

A proposed pineal-derived bioregulator with telomere-focused claims, not a mitochondrial-targeting peptide.

  • Evidence stagePreclinical
  • AvailabilityUnavailable
  • Batch recordPublished after verification
  • DispatchConfirmed at checkout

Out of stock

Ask about availability
SKU: ADINA-AGE-EPITHALON-10MG Category: Tags: , ,

PRODUCT INFORMATION

Clear first. Detailed when needed.

What this material is+

Epithalon is synthetic tetrapeptide ala-glu-asp-gly. Researchers examine it in relation to telomere, circadian and cellular-ageing hypotheses.

Research focus+

Researchers study ideas around cell ageing, telomeres and body-clock signals. These proposed longevity benefits are not established by strong, large human trials.

How the mechanism differs+

Reported in cell and animal studies to influence telomerase-related and pineal pathways; the mechanism is not clinically validated.

Evidence and limitations+

Evidence is largely preclinical or from small regional studies with limited independent replication.

Testing and batch documentation+

No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.

RESEARCH PROFILE

Understand the distinction.

Molecular role

Synthetic tetrapeptide Ala-Glu-Asp-Gly

Research focus

Researchers study ideas around cell ageing, telomeres and body-clock signals. These proposed longevity benefits are not established by strong, large human trials.

How it works

Reported in cell and animal studies to influence telomerase-related and pineal pathways; the mechanism is not clinically validated.

Key differentiator

A proposed pineal-derived bioregulator with telomere-focused claims, not a mitochondrial-targeting peptide.

Evidence context

Evidence is largely preclinical or from small regional studies with limited independent replication.

Educational research context only. This information is not dosage, administration or personal-use guidance.

CONTINUE EXPLORING

Related research perspectives.

Selected for useful comparison across neighbouring or contrasting research areas—not as combined-use guidance.